Form 8-K - Current report:
SEC Accession No. 0001437749-25-019767
Filing Date
2025-06-09
Accepted
2025-06-09 07:00:29
Documents
13
Period of Report
2025-06-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20250606_8k.htm   iXBRL 8-K 29895
  Complete submission text file 0001437749-25-019767.txt   160577

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20250606.xsd EX-101.SCH 3578
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20250606_def.xml EX-101.DEF 11423
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20250606_lab.xml EX-101.LAB 15309
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20250606_pre.xml EX-101.PRE 11583
15 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20250606_8k_htm.xml XML 2833
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 251032799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)